首页 › 基金 › Logos Global Management LP › ELVN

Logos Global Management LP 对 ELVN 的持仓历史

ENLIVEN THERAPEUTICS INC · 医疗保健

Logos Global Management LP 在 Q3 2026 的 13F 申报中披露持有 ELVN(ENLIVEN THERAPEUTICS INC)1,080,000 股,市值约 US$49.5M,约占其申报组合的 2.98%,在其申报持仓中市值排名第 10 位。 Logos Global Management LP 最近 13 个申报季度中有 13 个季度披露了 ELVN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)1.08M 股
申报持仓市值$49.51M
组合权重2.98%
首次申报Q3 2023
最近变动增持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Logos Global Management LP 对 ELVN 的持仓演变

Logos Global Management LP 于 Q3 2023 首次披露 ELVN 持仓:307,076 股(约 US$4.2M)。 该持仓在 Q3 2026 达到峰值 1,080,000 股,市值约 US$49.5M。 在 13 次申报中,Logos Global Management LP 5 次增持、5 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 1,080,000 股、市值约 US$49.5M,环比增持 615,000 股。。 持仓曾出现大幅变动:Q1 2024 增持约 413% (随后一个季度股价上涨 33%)、Q4 2024 减持约 72% (随后一个季度股价下跌 13%)、Q3 2026 增持约 132% (随后一个季度股价上涨 6%)。

逐季持仓明细

季度股数金额变化
Q3 2023 307.08K $4.19M 新进
Q4 2023 307.08K $4.25M 持有
Q1 2024 1.57M $26.41M 增持
Q2 2024 595.00K $13.91M 减持
Q3 2024 495.00K $12.64M 减持
Q4 2024 140.00K $3.15M 减持
Q1 2025 240.00K $4.72M 增持
Q2 2025 350.00K $7.02M 增持
Q3 2025 340.00K $6.96M 减持
Q4 2025 340.00K $5.24M 持有
Q1 2026 500.00K $19.60M 增持
Q2 2026 465.00K $23.60M 减持
Q3 2026 1.08M $49.51M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ELVN 与 13F 数据

ELVN(ENLIVEN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 61 只申报持有 ELVN,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$294.5M), Vestal Point Capital, LP (US$203.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ELVN 的基金

查看 ELVN 的全部基金持有人 →

常见问题

How long has Logos Global Management LP held ELVN?

Logos Global Management LP has disclosed ELVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Logos Global Management LP's current position in ELVN?

As of Q3 2026, Logos Global Management LP holds 1.08M shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $49.51M, representing 2.98% of its reported portfolio and ranking #10.

Has Logos Global Management LP been buying or selling ELVN?

In the latest 13F filing (Q3 2026), Logos Global Management LP increased its position in ELVN. The position peaked in Q3 2026 at 1.08M shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.